CCCC
Price
$2.15
Change
-$0.21 (-8.90%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
167.54M
58 days until earnings call
QNCX
Price
$1.49
Change
-$0.02 (-1.32%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
66.44M
63 days until earnings call
Ad is loading...

CCCC vs QNCX

Header iconCCCC vs QNCX Comparison
Open Charts CCCC vs QNCXBanner chart's image
C4 Therapeutics
Price$2.15
Change-$0.21 (-8.90%)
Volume$3.75K
Capitalization167.54M
Quince Therapeutics
Price$1.49
Change-$0.02 (-1.32%)
Volume$2.36K
Capitalization66.44M
CCCC vs QNCX Comparison Chart
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. QNCX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and QNCX is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (CCCC: $2.36 vs. QNCX: $1.51)
Brand notoriety: CCCC and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 31% vs. QNCX: 45%
Market capitalization -- CCCC: $167.54M vs. QNCX: $66.44M
CCCC [@Biotechnology] is valued at $167.54M. QNCX’s [@Biotechnology] market capitalization is $66.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileQNCX’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • QNCX’s FA Score: 1 green, 4 red.
According to our system of comparison, QNCX is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 3 TA indicator(s) are bullish while QNCX’s TA Score has 4 bullish TA indicator(s).

  • CCCC’s TA Score: 3 bullish, 3 bearish.
  • QNCX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CCCC and QNCX are a good buy in the short-term.

Price Growth

CCCC (@Biotechnology) experienced а -12.92% price change this week, while QNCX (@Biotechnology) price change was +4.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

CCCC is expected to report earnings on May 08, 2025.

QNCX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CCCC($168M) has a higher market cap than QNCX($66.4M). QNCX YTD gains are higher at: -19.251 vs. CCCC (-34.444). QNCX has higher annual earnings (EBITDA): -33.93M vs. CCCC (-103.45M). CCCC has more cash in the bank: 256M vs. QNCX (47.8M). QNCX has less debt than CCCC: QNCX (15.4M) vs CCCC (67.1M). CCCC has higher revenues than QNCX: CCCC (33.7M) vs QNCX (0).
CCCCQNCXCCCC / QNCX
Capitalization168M66.4M253%
EBITDA-103.45M-33.93M305%
Gain YTD-34.444-19.251179%
P/E RatioN/AN/A-
Revenue33.7M0-
Total Cash256M47.8M536%
Total Debt67.1M15.4M436%
FUNDAMENTALS RATINGS
QNCX: Fundamental Ratings
QNCX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCQNCX
RSI
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
83%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 28 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVS115.572.70
+2.39%
Novartis AG
GMED77.411.10
+1.44%
Globus Medical
KORE2.510.01
+0.40%
KORE Group Holdings
AKR22.51-0.01
-0.04%
Acadia Realty Trust
NWPX40.84-0.63
-1.52%
Northwest Pipe Company

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
N/A
KYMR - CCCC
59%
Loosely correlated
+1.08%
FATE - CCCC
49%
Loosely correlated
-2.88%
PRME - CCCC
48%
Loosely correlated
+4.35%
IMNM - CCCC
48%
Loosely correlated
+1.30%
CRBU - CCCC
48%
Loosely correlated
N/A
More

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been loosely correlated with MNPR. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if QNCX jumps, then MNPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
+0.67%
MNPR - QNCX
34%
Loosely correlated
-8.05%
CCCC - QNCX
33%
Poorly correlated
N/A
ADCT - QNCX
31%
Poorly correlated
+5.14%
CLNN - QNCX
29%
Poorly correlated
+1.10%
KOD - QNCX
28%
Poorly correlated
-3.72%
More